dose optimization for improved outcomes in refractory mcrc
Published 6 years ago • 100 plays • Length 8:32Download video MP4
Download video MP3
Similar videos
-
28:29
metastatic colorectal cancer: optimizing dosing strategy for late-line therapies
-
3:04
treatment goals in refractory mcrc
-
13:45
rectal cancer: optimal dose fractionation schedule of radiation therapy
-
18:55
emerging treatment options for mcrc patients in the late-line setting
-
7:08
the regorafenib dose optimization study
-
15:55
enhancing outcomes in metastatic colorectal cancer with angiogenesis inhibitors
-
26:09
how to improve on the outcome in ras mutant tumors
-
9:12
debate: is there an optimal treatment for refractory colorectal cancer? - immunotherapy
-
11:00
therapeutic sequencing & emerging therapies for mcrc
-
11:00
overview of late-line therapies for metastatic colorectal cancer
-
35:27
expert perspectives: optimizing late-line therapy for patients with metastatic colorectal cancer
-
8:36
debate: is there an optimal sequence for first-line therapy in mcrc? - yes
-
19:53
stage ii colon cancer: can we refine the selection for adjuvant treatment?
-
15:47
management of adverse events associated with third-line mcrc treatments
-
16:41
can we refine the selection for adjuvant treatment in stage ii colon cancer?
-
16:01
can we refine the selection for adjuvant treatment in colon cancer?
-
19:29
can we increase the immunogenicity in mss crc?
-
9:25
debate: msi high colon cancer - immunotherapy
-
3:27
improving outcomes in crc